Page 153 - EJMO-9-3
P. 153
Eurasian Journal of
Medicine and Oncology CRCI factors in breast cancer
doi: 10.3390/ijerph17238896 of cancer therapy: Cognitive function (FACT-Cog) in breast
cancer patients. J Clin Epidemiol. 2014;67(7):811-820.
9. Yao S, Zhang Q, Yao X, et al. Advances of neuroimaging
in chemotherapy related cognitive impairment (CRCI) doi: 10.1016/j.jclinepi.2014.01.010
of patients with breast cancer. Breast Cancer Res Treat. 19. Xiao SY. Theoretical basis and research application of social
2023;201:15-26.
support rating scale. J Clin Psychiatry. 1994;4(2):98-100.
doi: 10.1007/s10549-023-07005-y 20. Liu JY, Li FY, Lian YL. Investigation of reliability and
10. Regier NG, Naik AD, Mulligan EA, et al. Cancer-related validity of the social support scale. J Xinjiang Med Univ.
cognitive impairment and associated factors in a sample of 2008;31(1):1-3.
older male oral-digestive cancer survivors. Psychooncology. 21. Boscher C, Joly F, Clarisse B, et al. Perceived cognitive
2019;28(7):1551-1558. impairment in breast cancer survivors and its relationships
doi: 10.1002/pon.5131 with psychological factors. Cancers (Basel). 2020;12(10):3000.
11. McHugh Power JE, Lawlor BA, Kee F. Social support doi: 10.3390/cancers12103000
mediates the relationships between extraversion, 22. Abebe E, Tollesa T, Assefa M, et al. Cognitive functioning
neuroticism, and cognitive function in older adults. Public and its associated factors among breast cancer patients on
Health. 2017;147:144-152. chemotherapy at Tikur Anbessa specialized hospital, Addis
doi: 10.1016/j.puhe.2017.02.015 Ababa Ethiopia: An institution-based comparative cross-
sectional study. BMC Cancer. 2021;21(1):1052.
12. Ibrahim EY, Domenicano I, Nyhan K, et al. Cognitive effects
and depression associated with taxane-based chemotherapy doi: 10.1186/s12885-021-08799-0
in breast cancer survivors: A meta-analysis. Front Oncol. 23. Gunstad J, Paul RH, Cohen RA, et al. Obesity is associated
2021;11:642382. with memory deficits in young and middle-aged adults. Eat
doi: 10.3389/fonc.2021.642382 Weight Disord. 2006;11(1):e15-e19.
13. Das A, Ranadive N, Kinra M, Nampoothiri M, Arora D, doi: 10.1007/BF03327747
Mudgal J. An overview on chemotherapy-induced cognitive 24. Shefer G, Marcus Y, Stern N. Is obesity a brain disease?
impairment and potential role of antidepressants. Curr Neurosci Biobehav Rev. 2013;37(10 Pt 2):2489-2503.
Neuropharmacol. 2020;18(9):838-851.
doi: 10.1016/j.neubiorev.2013.07.015
doi: 10.2174/1570159X18666200221113842
25. Lamport DJ, Chadwick HK, Dye L, et al. A low glycaemic load
14. Durán-Gómez N, López-Jurado CF, Nadal-Delgado M, breakfast can attenuate cognitive impairments observed in
Pérez-Civantos D, Guerrero-Martín J, Cáceres MC. middle aged obese females with impaired glucose tolerance.
Chemotherapy-related cognitive impairment in patients Nutr Metab Cardiovasc Dis. 2014;24(10):1128-1136.
with breast cancer based on functional assessment and NIRS
analysis. J Clin Med. 2022;11(9):2363. doi: 10.1016/j.numecd.2014.04.015
doi: 10.3390/jcm11092363 26. Kanaya AM, Barrett-Connor E, Gildengorin G, et al. Change
in cognitive function by glucose tolerance status in older
15. Xu W, Wang K, Lian H. Linear convergence of decentralized adults: A 4-year prospective study of the Rancho Bernardo
estimation for statistical estimation using gradient method. study cohort. Arch Intern Med. 2004;164(12):1327-1333.
Neurocomputing. 2024;584:127584.
doi: 10.1001/archinte.164.12.1327
doi: 10.1016/j.neucom.2024.127584
27. Awad N, Gagnon M, Messier C. The relationship between
16. Wagner L, Sweet JJ, Butt Z, et al. Measuring patient self- impaired glucose tolerance, type 2 diabetes, and cognitive
reported cognitive function: Qualitative findings and initial function. J Clin Exp Neuropsychol. 2004;26(8):1044-1080.
development of the functional assessment of cancer therapy-
cognitive function (FACT-Cog) instrument. J Support Oncol. doi: 10.1080/13803390490517975
2009;7(6):W32-W39. 28. Dye L, Boyle NB, Champ CL, Lawton CL. The relationship
17. Cheung YT, Si RL, Shwe M, et al. Psychometric properties between obesity and cognitive health and decline. Proc Nutr
and measurement equivalence of the English and Chinese Soc. 2017;76(4):443-454.
versions of the functional assessment of cancer therapy- doi: 10.1017/S0029665117002014
cognitive in Asian patients with breast cancer. Value Health. 29. Kesler SR, Blayney DW. Neurotoxic effects of
2013;16(6):1001-1013.
anthracycline- vs nonanthracycline-based chemotherapy
doi: 10.1016/j.jval.2013.06.013 on cognition in breast cancer survivors. JAMA Oncol.
2016;2(2):185-192.
18. Cheung YT, Foo YL, Shwe M, et al. Minimal clinically
important difference (MCID) for the functional assessment doi: 10.1001/jamaoncol.2015.4333
Volume 9 Issue 3 (2025) 145 doi: 10.36922/EJMO025130073

